LOGIN
Dexamethasone & Dexmedetomidine + Ropivacaine In Wound Infiltration For Lumbar Spinal Fusion
April 2024
Dexamethasone & Dexmedetomidine + Ropivacaine In Wound Infiltration For Lumbar Spinal Fusion
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Dexamethasone and dexmedetomidine as adjuvants to ropivacaine do not prolong analgesia in wound infiltration for lumbar spinal fusion: a prospective randomized controlled study.
J Orthop Surg Res . 2023 Sep 4;18(1):654.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
72 patients undergoing surgery for transforaminal lumbar interbody fusion were randomized into ropivacaine alone (R; n=18), or ropivacaine plus either dexamethasone (R-DXM; n=18), dexmedetomidine (R-DEX; n=18), or dexamethasone and dexmedetomidine (R-DXM+DEX; n=18). The primary outcome of interest was the duration of analgesia. Secondary outcomes included the incidence of adverse events, hydromorp...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.